Prognosis evaluation of a great dane dog with dilated cardiomyopathy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A five-year-old, male, Great Dane weighing 107 kg was presented with anorexia, abdominal distension, and dyspnea for 5 days. Physical examination, blood works, radiography, electrocardiography (ECG), and echocardiography were performed. Based on severely low fractional shortening (FS) and marked four chamber enlargement in echocardiography, continuous atrial fibrillation and occasional ventricular premature complex (VPC) on ECG, the dog was diagnosed as dilated cardiomyopathy (DCM) concurrent with congestive heart failure. Pleural effusion and ascites were modified transudate. In accordance with DCM scoring system recommended by European Society of Veterinary Cardiology (ESVC), DCM score was 13/15 in this case. Concentrations of cTnI and NT-pro-BNP were 1.0 ng/mL and 693 pmol/L, respectively. Since the former and the latter were remarkably high values, it was certain that the patient had grave prognosis. Intensive care was performed for the dog and the clinical signs as well as the radiographic abnormalities were resolved. However, when he presented serious dyspnea again at 25 days post therapy, the dog was dead. In case of canine DCM, the scoring system for the diagnosis and cardiac biomarkers including NT-pro-BNP and cTnI could be useful to advise owners on the status and prognosis of their dog with DCM.
Abstract
A five-year-old, male, Great Dane weighing 107 kg was presented with anorexia, abdominal distension, and dyspnea for 5 days. Physical examination, blood works, radiography, electrocardiography (ECG), and echocardiography were performed. Based on severely low fractional shortening (FS) and marked four chamber enlargement in echocardiography, continuous atrial fibrillation and occasional ventricular premature complex (VPC) on ECG, the dog was diagnosed as dilated cardiomyopathy (DCM) concurrent with congestive heart failure. Pleural effusion and ascites were modified transudate. In accordance with DCM scoring system recommended by European Society of Veterinary Cardiology (ESVC), DCM score was 13/15 in this case. Concentrations of cTnI and NT-pro-BNP were 1.0 ng/mL and 693 pmol/L, respectively. Since the former and the latter were remarkably high values, it was certain that the patient had grave prognosis. Intensive care was performed for the dog and the clinical signs as well as the radiographic abnormalities were resolved. However, when he presented serious dyspnea again at 25 days post therapy, the dog was dead. In case of canine DCM, the scoring system for the diagnosis and cardiac biomarkers including NT-pro-BNP and cTnI could be useful to advise owners on the status and prognosis of their dog with DCM.
참고문헌 (33)
- Borgarelli M, "Prognostic indicators for dogs with dilated cardiomyopathy", J Vet Intern Med, 20, pp.104~110 (2006)
- Boswood A, "The diagnostic accuracy of different natriuretic peptides in the investigation of canine cardiac disease", J Small Anim Pract, 49, pp.26~32 (2008)
- Calvert CA, "Signalment, Survival, and Prognostic Factors in Doberman Pinschers With End‐Stage Cardiomyopathy", J Vet Intern Med, 11, pp.323~326 (1997)
- Calvert CA, "Results of ambulatory electrocardiography in overtly healthy Doberman Pinschers with equivocal echocardiographic evidence of dilated cardiomyopathy", J Am Vet Med Assoc, 219, pp.782~784 (2001)
- Dukes-McEwan J, "Proposed guidelines for the diagnosis of canine idiopathic dilated cardiomyopathy", J Vet Cardiol, 5, pp.7~19 (2003)
- Fonfara S, "Cardiac troponin I as a marker for severity and prognosis of cardiac disease in dogs", Vet J, 184, pp.334~339 (2010)
- Fox PR, "Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats", J Vet Cardiol, 11, pp.S51~S61 (2009)
- Keene B, "Myocardial L-carnitine deficiency in a family of dogs with dilated cardiomyopathy", J Am Vet Med Assoc, 198, pp.647~650 (1991)
- Kittleson MD, "Results of the Multicenter Spaniel Trial(MUST) : Taurine‐and Carnitine‐Responsive Dilated Cardiomyopathy in American Cocker Spaniels With Decreased Plasma Taurine Concentration", J Vet Intern Med, 11, pp.204~211 (1997)
- Koch J, "M‐mode Echocardiographic Diagnosis of Dilated Cardiomyopathy in Giant Breed Dogs", J Vet Intern Med Series A, 43, pp.297~304 (1996)
- Limas C, "Autoantibodies against beta-adrenoceptors in human idiopathic dilated cardiomyopathy", Circ Res, 64, pp.97~ (1989)
- Martin M, "Canine dilated cardiomyopathy : a retrospective study of signalment, presentation and clinical findings in 369 cases", J Small Anim Pract, 50, pp.23~29 (2009)
- Martin M, "Canine dilated cardiomyopathy : a retrospective study of prognostic findings in 367 clinical cases", J Small Anim Pract, 51, pp.428~436 (2010)
- Menaut P, "Atrial fibrillation in dogs with and without structural or functional cardiac disease : a retrospective study of 109 cases", J Vet Cardiol, 7, pp.75~83 (2005)
- Meurs KM, "Clinical features of dilated cardiomyopathy in Great Danes and results of a pedigree analysis : 17 cases(1990-2000)", J Am Vet Med Assoc, 218, pp.729~732 (2001)
- Monnet E, "Idiopathic dilated cardiomyopathy in dogs : survival and prognostic indicators", J Vet Intern Med, 9, pp.12~17 (1995)
- Noszczyk-Nowak A, "NT-pro-BNP and troponin I as predictors of mortality in dogs with heart failure", Pol J Vet Sci, 14, pp.551~556 (2011)
- O'Sullivan ML, "Plasma Big Endothelin‐1, Atrial Natriuretic Peptide, Aldosterone, and Norepinephrine Concentrations in Normal Doberman Pinschers and Doberman Pinschers with Dilated Cardiomyopathy", J Vet Intern Med, 21, pp.92~99 (2007)
- Olson TM, "Actin mutations in dilated cardiomyopathy, a heritable form of heart failure", Science, 280, pp.750~752 (1998)
- Oyama MA, "Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease", J Am Vet Med Assoc, 243, pp.71~82 (2013)
- Oyama MA, "Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity", J Am Vet Med Assoc, 232, pp.1496~1503 (2008)
- Oyama MA, "Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations", Am J Vet Res, 68, pp.42~47 (2007)
- Oyama MA, "Cardiac Troponin‐I Concentration in Dogs with Cardiac Disease", J Vet Intern Med, 18, pp.831~839 (2004)
- Sandusky GE, "Congestive cardiomyopathy in a dog associated with pregnancy", Cornell Vet, 74, pp.60~64 (1984)
- Schultheiss H, "Immunological analysis of auto-antibodies against the adenine nucleotide translocator in dilated cardiomyopathy", J Mol Cell Cardiol, 17, pp.603~617 (1985)
- Sisson DD, "Textbook of veterinary internal medicine 5th edition Philadelphia", pp.874~895 (2000), WB Saunders
- Sleeper, MM, "Cardiac troponin I in the normal dog and cat", J Vet Intern Med, 15, pp.501~503 (2001)
- Tarnow I, "Predictive value of natriuretic peptides in dogs with mitral valve disease", Vet J, 180, pp.195~201 (2009)
- Tidholm A, "Canine idiopathic dilated cardiomyopathy. Part I: aetiology, clinical characteristics, epidemiology and pathology", Vet J, 162, pp.92~107 (2001)
- Tidholm A, "Survival in dogs with dilated cardiomyopathy and congestive heart failure treated with digoxin, furosemide and propranolol: A retrospective study of 62 dogs", J Vet Cardiol, 8, pp.41~47 (2006)
- Wess G, "Evaluation of N-terminal pro-B-type natriuretic peptide as a diagnostic marker of various stages of cardiomyopathy in Doberman Pinschers", Am J Vet Res, 72, pp.642~649 (2011)
- Wess G, "Prevalence of dilated cardiomyopathy in Doberman Pinschers in various age groups", J Vet Intern Med, 24, pp.533~538 (2010)
- Wynne J, "Heart disease: a textbook of cardiovascular medicine", pp.1751~1806 (2001), WB Saunders